Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 1, 2009, Pages 54-61

  Aguiar, Fabio ^a   Vieira, M A ^a   Staviack, A ^a   Buarque, C ^a   Marsico, A ^a   Fonseca, L ^a   Chaisson, R ^b   Kristski, A ^a   Werneck, G ^a,c   Mello, F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Drug resistance; Hospital infection control programme; Multidrug resistant TB; Transmissible disease control; Tuberculosis chemotherapy

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIUM ISOLATION; DEMOGRAPHY; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG CAVITY; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK FACTOR; SEROLOGY; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADULT; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALS, URBAN; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 58149402093     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Raviglione M C, Gupta R, Dye C M, Espinal M A. The burden of drug-resistant tuberculosis and mechanisms for its control. Ann N Y Acad Sci 2001; 953: 88-97.
2. World Health Organization. WHO report 2006: global tuberculosis control, surveillance, planning, financing. WHO/HTM/STB/2006.371. Geneva, Switzerland: WHO, 2006.
3. Programa de Controle de Tuberculose do Município do Rio de Janeiro. Boletim informativo do programa de controle de tuberculose do município do Rio de Janeiro, 2004. Rio de Janeiro, Rio de Janeiro, Brazil: PCT, 2004. [Brazilian]
4. Soares E C, Pacheco A G, Mello F C, Durovni B, Chaisson R E, Cavalcante S C. Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City. Int J Tuberc Lung Dis 2006; 10: 690-695.
5. Espinal M A. The global situation of MDR-TB. Tuberculosis [Edinburgh] 2003; 83: 44-51.
6. Salaniponi F M, Nyirenda T E, Kemp J R, Squire S B, Godfrey-Faussett P, Harries A D. Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis 2003; 7: 948-952.
7. Lee J H, Chang J H. Drug-resistant tuberculosis in a tertiary referral teaching hospital of Korea. Korean J Intern Med 2001; 16: 173-179.
8. Yoshiyama T, Supawitkul S, Kunyanone N, et al. Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. Int J Tuberc Lung Dis 2001; 5: 32-39.
9. Balci I, Dikensoy O, Bayram A, Filiz A. Drug-resistant tuberculosis at the University Hospital in Gaziantep, south-eastern Turkey. J Int Med Res 2000; 28: 300-306.
10. Liaw Y S, Hsueh P R, Yu C J, Wang S K, Yang P C, Luh K T. Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. J Formos Med Assoc 2004; 103: 671-677.
11. Nunes E A, De Capitani E M, Coelho E, et al. Patterns of antituberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003. Int J Tuberc Lung Dis 2005; 9: 494-500.
12. Harrow E M, Rangel J M, Arriega J M, et al. Epidemiology and clinical consequences of drug-resistant tuberculosis in a Guatemalan hospital. Chest 1998; 113: 1452-1458.
13. Lin J, Sattar A N, Puckree T. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. Int J Tuberc Lung Dis 2004; 8: 568-573.
14. Senol G, Komurcuoglu B, Komurcuoglu A. Drug resistance of Mycobacterium tuberculosis in western Turkey: a retrospective study from 1100-bed teaching hospital. J Infect 2005; 50: 306-311.
15. Liu C E, Chen C H, Hsiao J H, Young T G, Tsay R W, Fung C P. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. J Microbiol Immunol Infect 2004; 37: 295-300.
16. Willingham F F, Schmitz T L, Contreras M, et al. Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerg Infect Dis 2001; 7: 123-127.
17. Reechaipichitkul W. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 570-574.
18. Braga J U B A, Hijjar M A. Inquérito epidemiológico da resistência às drogas usadas no tratamento da tuberculose no Brasil 1995-97, IERDTB. Parte III: principals resultados. Bol Pneumol Sanit 2003; 11: 76-81. [Brazilian]
19. Fandinho F, Kritski A, Hofer C, et al. Drug resistance patterns among hospitalized tuberculous patients in Rio de Janeiro, Brazil, 1993-1994. Mem Inst Oswaldo Cruz 1999; 94: 543-547. [Brazilian]
20. Brito R C G C, Lima D B, Siqueira H, Cavalcanti H R, Pereira M M, Kritski A L. Resistência aos medicamentos anti-tuberculose de cepas de Mycobacterium tuberculosis isoladas de pacientes atendidos em hospital geral de referência para tratamento de AIDS no Rio de Janeiro. J Pneumol 2004; 30: 425-432. [Brazilian]
21. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131: 1121-1123.
22. The International Union Against Tuberculosis and Lung Disease. Technical guide: sputum examination for tuberculosis by direct microscopy in low-income countries. Paris, France: The Union, 2000.
23. Canetti G, Froman S, Grosset J, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 14.
24. Barros A J, Hirakata V N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003; 3: 21.
25. World Health Organization. Communicable diseases. Stop TB. DOTS-Plus: preliminary results and emerging issues. WHO/CDS/TB/2002.307. Geneva, Switzerland: WHO, 2002.
26. Programa de Controle de Tuberculose do Município do Rio de Janeiro. Boletim informativo do programa de controle de tuberculose do município do Rio de Janeiro, 2003. Rio de Janeiro, Rio de Janeiro, Brazil: PCT, 2003.
27. Casai M, Vaquero M, Rinder H, et al. A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 2005; 11: 62-67.
28. Faustini A, Hall A J, Perucci C A. Risk factors for multidrug-resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
29. Natal S, Valente J G, Sanchez A R, Penna M L. [Isoniazid and rifampicin resistance and prior treatment for tuberculosis]. Cad Saude Publica 2003; 19: 1277-1281. [Brazilian]
30. Ruddy M, Balabanova Y, Graham C, et al. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 2005; 60: 130-135.
31. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
32. Morris J T, McAllister C K. Homeless individuals and drug-resistant tuberculosis in south Texas. Chest 1992; 102: 802-804.
33. Dalcolmo M P, Fortes A, Melo F F, Motta R, et al. Estudo de efetividade de esquemas alternativos para o tratamento da tuberculose multirresistente no Brasil. J Pneumol 1999; 25: 63-69. [Brazilian]
34. Sharma S K, Turaga K K, Balamurugan A, et al. Clinical and genetic risk factors for the development of multi-drug resistant tuberculosis in non-HIV infected patients at a tertiary care center in India: a case-control study. Infect Genet Evol 2003; 3: 183-188.